DexCom, Inc.DexCom, Inc.DexCom, Inc.

DexCom, Inc.

No trades
See on Supercharts
Market capitalization
‪52.63 B‬USD
‪541.50 M‬USD
‪3.62 B‬USD
‪377.37 M‬
Beta (1Y)
1.05

About DexCom, Inc.

CEO
Kevin Ronald Sayer
Website
Headquarters
San Diego
Employees (FY)
‪9.6 K‬
Founded
1999
ISIN
US2521311074
FIGI
BBG000QTF8K1
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of DXCM is 133.86 USD — it has decreased by 1.95% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange DexCom, Inc. stocks are traded under the ticker DXCM.
DexCom, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for DexCom, Inc. has a max estimate of 170.00 USD and a min estimate of 122.00 USD.
DXCM earnings for the last quarter are 0.50 USD whereas the estimation was 0.34 USD which accounts for 46.77% surprise. Estimated earnings for the next quarter are 0.43 USD. See more details about DexCom, Inc. earnings.
DexCom, Inc. revenue for the last quarter amounts to ‪975.00 M‬ USD despite the estimated figure of ‪939.64 M‬ USD. In the next quarter revenue is expected to reach ‪1.02 B‬ USD.
Yes, you can track DexCom, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, DXCM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DexCom, Inc. stock right from TradingView charts — choose your broker and connect to your account.
DXCM reached its all-time high on Nov 18, 2021 with the price of 164.86 USD, and its all-time low was 0.34 USD and was reached on Nov 20, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪9.60 K‬ employees. See our rating of the largest employees — is DexCom, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DexCom, Inc. EBITDA is ‪783.70 M‬ USD, and current EBITDA margin is 21.64%. See more stats in DexCom, Inc. financial statements.